NIAID Banner Logo Image

HIV Citations List: July, 2017

Literature Citations

1. Inhibition of Non Canonical HIV-1 Tat Secretion through the Cellular Na+,K+-ATPase Blocks HIV-1 Infection.Agostini, S., H. Ali, C. Vardabasso, A. Fittipaldi, E. Tasciotti, A. Cereseto, A. Bugatti, M. Rusnati, M. Lusic, and M. Giacca. EBioMedicine, 2017. 21: p. 170-181. PMID[28645727]. PMCID[PMC5514404].
[PubMed]. HIV_07_2017.


2. Synthesis, X-Ray Structure, in Vitro HIV and Kinesin Eg5 Inhibition Activities of New Arene ruthenium Complexes of Pyrimidine Analogs. Al-Masoudi, W.A., N.A. Al-Masoudi, B. Weibert, and R. Winter. Journal of Coordination Chemistry, 2017. 70(12): p. 2061-2073. ISI[000403665700008].
[WOS]. HIV_07_2017.


3. Novel Anti-inflammatory Agents Targeting CXCR4: Design, Synthesis, Biological Evaluation and Preliminary Pharmacokinetic Study. Bai, R., Z. Liang, Y. Yoon, E. Salgado, A. Feng, S. Gurbani, and H. Shim. European Journal of Medicinal Chemistry, 2017. 136: p. 360-371. PMID[28521261]. PMCID[PMC5521218].
[PubMed]. HIV_07_2017.


4. Synthesis, Structural Studies and Biological Evaluation of Halogen Derivatives of 1,3-Disubstituted thiourea.Bielenica, A., K. Stepien, A. Sawczenko, T. Lis, A.E. Koziol, S. Madeddu, D. Collu, F. Iuliano, A. Kosmider, and M. Struga. Letters in Drug Design & Discovery, 2017. 14(6): p. 636-646. ISI[000404984700001].
[WOS]. HIV_07_2017.


5. G2-S16 Dendrimer as a Candidate for a Microbicide to Prevent HIV-1 Infection in Women. Cena-Diez, R., P. Garcia-Broncano, F. Javier de la Mata, R. Gomez, S. Resino, and M. Munoz-Fernandez. Nanoscale, 2017. 9(27): p. 9732-9742. PMID[28675217].
[PubMed]. HIV_07_2017.


6. Structure-Activity Relationships of N-Cinnamoyl and Hydroxycinnamoyl amides on alpha-Glucosidase Inhibition. Chochkova, M.G., P.P. Petrova, B.M. Stoykova, G.I. Ivanova, M. Sticha, G. Dibo, and T.S. Milkova. Journal of Chemistry, 2017. 6080129: 5pp. ISI[000405247900001].
[WOS]. HIV_07_2017.


7. The Histone Deacetylase Inhibitor SAHA Simultaneously Reactivates HIV-1 from Latency and Up-regulates NKG2D Ligands Sensitizing for Natural Killer Cell Cytotoxicity. Desimio, M.G., E. Giuliani, and M. Doria. Virology, 2017. 510: p. 9-21. PMID[28689087].
[PubMed]. HIV_07_2017.


8. Searching for Novel N1-Substituted benzimidazol-2-ones as Non-Nucleoside HIV-1 RT Inhibitors. Ferro, S., M.R. Buemi, L. De Luca, F.E. Agharbaoui, C. Pannecouque, and A.M. Monforte. Bioorganic & Medicinal Chemistry, 2017. 25(14): p. 3861-3870. PMID[28559060].
[PubMed]. HIV_07_2017.


9. Encapsulation of Ritonavir in Solid Lipid Nanoparticles: In-Vitro anti-HIV-1 Activity Using Lentiviral Particles.Javan, F., A. Vatanara, K. Azadmanesh, M. Nabi-Meibodi, and M. Shakouri. Journal of Pharmacy and Pharmacology, 2017. 69(8): p. 1002-1009. PMID[28471000].
[PubMed]. HIV_07_2017.


10. Degradation of Heme oxygenase-1 by the Immunoproteasome in Astrocytes: A Potential Interferon-Gamma-dependent Mechanism Contributing to HIV Neuropathogenesis. Kovacsics, C.E., A.J. Gill, S.S. Ambegaokar, B.B. Gelman, and D.L. Kolson. GLIA, 2017. 65(8): p. 1264-1277. PMID[28543773].
[PubMed]. HIV_07_2017.


11. Anti-HIV-1 ADCC Antibodies Following Latency Reversal and Treatment Interruption. Lee, W.S., A.B. Kristensen, T.A. Rasmussen, M. Tolstrup, L. Ostergaard, O.S. Sogaard, B.D. Wines, P.M. Hogarth, A. Reynaldi, M.P. Davenport, S. Emery, J. Amin, D.A. Cooper, V.L. Kan, J. Fox, H. Gruell, M.S. Parsons, and S.J. Kent. Journal of Virology, 2017. 91(15): e00603-17. PMID[28539449]. PMCID[PMC5512246].
[PubMed]. HIV_07_2017.


12. Synthesis and Antiviral Evaluation of Base-modified Deoxythreosyl nucleoside phosphonates. Liu, C., S.G. Dumbre, C. Pannecouque, B. Korba, S. De Jonghe, and P. Herdewijn. Organic & Biomolecular Chemistry, 2017. 15(26): p. 5513-5528. PMID[28628181].
[PubMed]. HIV_07_2017.


13. Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl acyclic nucleoside phosphonates: Diamyl aspartate amidate Prodrugs. Luo, M., E. Groaz, G. Andrei, R. Snoeck, R. Kalkeri, R.G. Ptak, T. Hartman, R.W. Buckheit, Jr., D. Schols, S. De Jonghe, and P. Herdewijn. Journal of Medicinal Chemistry, 2017. 60(14): p. 6220-6238. PMID[28682067].
[PubMed]. HIV_07_2017.


14. Structure-based Identification of Inhibitors Targeting Obstruction of the HIVgp41 N-Heptad Repeat Trimer.McGee, T.D., Jr., H.A. Yi, W.J. Allen, A. Jacobs, and R.C. Rizzo. Bioorganic & Medicinal Chemistry Letters, 2017. 27(14): p. 3177-3184. PMID[28558972].
[PubMed]. HIV_07_2017.


15. Eutypellazines A-M, Thiodiketopiperazine-type Alkaloids from Deep Sea Derived Fungus Eutypella sp. MCCC 3A00281.Niu, S., D. Liu, Z. Shao, P. Proksch, and W. Lin. RSC Advances, 2017. 7(53): p. 33580-33590. ISI[000404864100065].
[WOS]. HIV_07_2017.


16. Antiretroviral Activity of a Novel Pyrimidyl-di(diazaspiroalkane) Derivative. Novoselova, E.A., O.B. Riabova, I.A. Leneva, V.G. Nesterenko, R.N. Bolgarin, and V.A. Makarov. Acta Naturae, 2017. 9(1): p. 105-107. PMID[28461981]. PMCID[PMC5406667].
[PubMed]
. HIV_07_2017.


17. Anti-HIV Antibody and Drug Combinations Exhibit Synergistic Activity against Drug-resistant HIV-1 Strains.Qi, Q., Q. Wang, W. Chen, F. Yu, L. Du, D.S. Dimitrov, L. Lu, and S. Jiang. The Journal of Infection, 2017. 75(1): p. 68-71. PMID[28322889].
[PubMed]. HIV_07_2017.


18. Synthesis and Structural Characterization of New Bioactive Ligands and Their Bi(III) Derivatives.Raheel, A., Imtiaz-ud-Din, S. Andleeb, S. Ramadan, and M.N. Tahir. Applied Organometallic Chemistry, 2017. 31(6): e3632. ISI[000403705700012].
[WOS]. HIV_07_2017.


19. Anti-proliferative Therapy for HIV Cure: A Compound Interest Approach. Reeves, D.B., E.R. Duke, S.M. Hughes, M. Prlic, F. Hladik, and J.T. Schiffer. Scientific Reports, 2017. 7(4011): 10pp. PMID[28638104]. PMCID[PMC5479830].
[PubMed]. HIV_07_2017.


20. Synthesis of Potential HIV Integrase Inhibitors Inspired by Natural Polyphenol Structures. Righi, G., R. Pelagalli, V. Isoni, I. Tirotta, M. Marini, M. Palagri, R. Dallocchio, A. Dessi, B. Macchi, C. Frezza, G. Forte, A. Dalla Cort, G. Portalone, and P. Bovicelli. Natural Product Research, 2017: p. 1-9. PMID[28748719].
[PubMed]. HIV_07_2017.


21. Evaluation of Biological Activity of Mastic Extracts Based on Chemotherapeutic Indices. Suzuki, R., H. Sakagami, S. Amano, K. Fukuchi, K. Sunaga, T. Kanamoto, S. Terakubo, H. Nakashima, Y. Shirataki, M. Tomomura, Y. Masuda, S. Yokose, A. Tomomura, H. Watanabe, M. Okawara, and Y. Matahira. In Vivo, 2017. 31(4): p. 591-598. PMID[28652425].
[PubMed]. HIV_07_2017.


22. Synthesis and Biological Evaluation of Chemokine Receptor Ligands with 2-Benzazepine Scaffold.Thum, S., A.K. Kokornaczyk, T. Seki, M. De Maria, N.V.O. Zacarias, H. de Vries, C. Weiss, M. Koch, D. Schepmann, M. Kitamura, N. Tschammer, L.H. Heitman, A. Junker, and B. Wuensch. European Journal of Medicinal Chemistry, 2017. 135: p. 401-413. PMID[28463783].
[PubMed]. HIV_07_2017.


23. Discovery and Characterization of a Novel CD4-Binding Adnectin with Potent anti-HIV Activity. Wensel, D., Y. Sun, Z. Li, S. Zhang, C. Picarillo, T. McDonagh, D. Fabrizio, M. Cockett, M. Krystal, and J. Davis. Antimicrobial Agents and Chemotherapy, 2017. 61(8): e00508-17. PMID[28584151].
[PubMed]. HIV_07_2017.


24. MK-8591 (4'-Ethynyl-2-fluoro-2'-deoxyadenosine) Exhibits Potent Activity against HIV-2 Isolates and Drug-resistant HIV-2 Mutants in Culture.Wu, V.H., R.A. Smith, S. Masoum, D.N. Raugi, S. Ba, M. Seydi, J.A. Grobler, and G.S. Gottlieb. Antimicrobial Agents and Chemotherapy, 2017. 61(8): e00744-17. PMID[28559249].
[PubMed]. HIV_07_2017.


25. Discovery of Novel Small-molecule Inhibitors of Lim Domain Kinase for Inhibiting HIV-1. Yi, F., J. Guo, D. Dabbagh, M. Spear, S. He, K. Kehn-Hall, J. Fontenot, Y. Yin, M. Bibian, C.M. Park, K. Zheng, H.J. Park, V. Soloveva, D. Gharaibeh, C. Retterer, R. Zamani, M.L. Pitt, J. Naughton, Y. Jiang, H. Shang, R.M. Hakami, B. Ling, J.A.T. Young, S. Bavari, X. Xu, Y. Feng, and Y. Wu. Journal of Virology, 2017. 91(13): e02418-16. PMID[28381571]. PMCID[PMC5469273].
[PubMed]. HIV_07_2017.

Patent Citations

26. Preparation of C-3 Triterpenone Derivatives as HIV Inhibitors. Bandi, P.R., R.R. Kura, D.K. Gazula Levi, P.R. Adulla, and B.R. Kasireddy. Patent. 2017. 2016-IB58104 2017115329: 315pp.
[Patent]. HIV_07_2017.


27. D-Peptides Compositions for Inhibiting HIV Entry into Host Cells. Welch, B.D., J.N. Francis, and M.S. Kay. Patent. 2017. 2017-US12640 2017120549: 91pp.
[Patent]. HIV_07_2017.


28. Preparation of Fused Tricyclic Heterocycles as HIV Integrase Inhibitors for the Treatment and Prophylaxis of HIV Infection. Yu, T., S.T. Waddell, T.H. Graham, J.A. McCauley, A.W. Stamford, J. Cai, and Z. Qi. Patent. 2017. 2015-CN100106 2017113288: 70pp.
[Patent]. HIV_07_2017.


29. Preparation of Fused Tricyclic Heterocycles as HIV Integrase Inhibitors for the Treatment and Prophylaxis of HIV Infection. Yu, T., S.T. Waddell, T.H. Graham, Y. Zhang, J.A. McCauley, A.W. Stamford, J. Cai, and Z. Qi. Patent. 2017. 2016-US68173 2017116928: 83pp.
[Patent]. HIV_07_2017.


30. Spirocyclic Quinolizine Derivatives Useful as HIV Integrase Inhibitors. Zhang, Y., S.T. Waddell, T. Yu, J.A. McCauley, and A. Stamford. Patent. 2017. 2016-US66078 2017106071: 68pp.
[Patent]. HIV_07_2017.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2021